Antiviral Therapy May Prevent Liver Cancer in Hepatitis C Patients

Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma.

This finding is part of a study published in the May issue of Clinical Gastroenterology and Hepatology. Investigators from Henry Ford Health System in Detroit, Geisinger Health System in Danville, Pa., and Kaiser Permanente in Honolulu, Hawaii and Portland, Ore., participated in the study, along with investigators from the Centers for Disease Control and Prevention.